Ask Questions (ASQ):Implementation of a Communication Intervention
This clinical trial implements a communication intervention to improve patient-oncologist communication in the outpatient medical oncology setting. A communication brochure called the ASQ brochure may help patients prepare for the doctor visit by thinking through the questions that patients and patients' family want to ask the doctor.
Checked against the public recordLast updated Aug 16, 2023 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Health Services Research
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Interventions being studied
- Behavioral: Behavioral Intervention
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Adults 18 years of age or older * Have a first appointment to see a medical oncologist at a Karmanos Cancer Institute (KCC) site for medical/systemic treatment for a new, confirmed diagnosis of stages I-IV cancer * Speak and read English well enough to be able to understand consent documents * Given the diverse population seen at KCI, we will make attempts to recruit a representative sample. Our strategy will be simply to ask recruiters to make special attempts to recruit a representative sample. If that strategy fails after the first 10 patients we will build in requirements that at least 25% of the patients self-identify as non-White Exclusion Criteria: * Not specified
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Karmanos Cancer Institute at McLaren Bay RegionBay City, Michigan
- Karmanos Cancer Institute at McLaren ClarkstonClarkston, Michigan
- Karmanos Cancer InstituteDetroit, Michigan
- Karmanos Cancer Institute at McLaren FlintFlint, Michigan
- Karmanos Cancer Institute at McLaren MacombMount Clemens, Michigan
- Karmanos Cancer Institute at McLaren Central MichiganMount Pleasant, Michigan
- Karmanos Cancer Institute at McLaren Northern MichiganPetoskey, Michigan
- Karmanos Cancer Institute at McLaren Port HuronPort Huron, Michigan
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Aug 16, 2023. Always confirm current availability with the study team.